An anchored simulated treatment comparison of uptitration of amlodipine compared with a low-dose combination treatment with amlodipine 5 mg/bisoprolol 5 mg for patients with hypertension suboptimally controlled by amlodipine 5 mg monotherapy-Reference-Cited by-同舟云学术

An anchored simulated treatment comparison of uptitration of amlodipine compared with a low-dose combination treatment with amlodipine 5 mg/bisoprolol 5 mg for patients with hypertension suboptimally controlled by amlodipine 5 mg monotherapy

Published:2022-02-01 Issue:4 Volume:38 Page:587-593
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Foch Caroline¹^ORCID,Feifel Jan¹^ORCID,Gottwald-Hostalek Ulrike²^ORCID

Affiliation:

1. Global Epidemiology, Merck Healthcare KGaA, Darmstadt, Germany

2. Global Medical Affairs, Merck Healthcare KGaA, Darmstadt, Germany

Funder

Merck Healthcare KGaA

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/03007995.2022.2030112

Reference19 articles.

1. 2018 ESC/ESH Guidelines for the management of arterial hypertension

2. The combination of amlodipine/valsartan 5/160 mg produces less peripheral oedema than amlodipine 10 mg in hypertensive patients not adequately controlled with amlodipine 5 mg

3. Antihypertensive Efficacy of the Oral Direct Renin Inhibitor Aliskiren as Add-On Therapy in Patients Not Responding to Amlodipine Monotherapy

4. EudraCT Number: 2019-000751-13. EU Clinical Trials Register; [cited 2021 Nov 26]. Available from: https://www.clinicaltrialsregister.eu/ctr-search/trial/2019-000751-13/PL.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Contribution of single-pill combinations in the management of hypertension: perspectives from China, Europe and the USA;Current Medical Research and Opinion;2023-01-20

2. A growing evidence base for the fixed-dose combination of bisoprolol and amlodipine to manage hypertension;Current Medical Research and Opinion;2022-05-13